Results 31 to 40 of about 28,714 (188)
Prevalence and risk factors of tigecycline-induced liver injury: A multicenter retrospective study
International Journal of Infectious Diseases, 2022 : Objective: We conducted this multicenter retrospective study to evaluate the prevalence, clinical patterns, and risk factors for tigecycline-induced liver injury, which is a type of drug-induced liver injury (DILI).
Zhenwei Yu +5 more
doaj +1 more source
Induction of Tigecycline Resistance in Acinetobacter baumannii
Bio-Protocol, 2014 Multidrug resistance Acinetobacter baumannii (A. baumannii) (MDRAB) has emerged as a serious threat in hospitals in recent years. Currently, there are few antibiotics, including tigecycline, available to treat infections caused by MDRAB effectively. Both
Ming-Feng Lin, Yun-You Lin, Chung-Yu Lan
doaj +1 more source
Antibiotics, 2020 Tigecycline offers broad anti-bacterial coverage for critically ill patients with complicated infections. A described but less researched side effect is coagulopathy.
Anna Brandtner +9 more
doaj +1 more source
Frontiers in Microbiology, 2021 Tigecycline has been used as one of the therapeutic choices for the treatment of infections caused by multidrug-resistant Klebsiella pneumoniae. However, the emergence of tigecycline heteroresistance has led to great challenges in treating these ...
Qiaoyu Zhang +3 more
doaj +1 more source
In vitro and in vivo antibacterial activity of tigecycline against Vibrio vulnificus
Journal of Microbiology, Immunology and Infection, 2018 Background/purpose: The aim of this study is to investigate the role of tigecycline in Vibrio vulnificus infection. Methods: Eight randomly selected clinical V.
Hung-Jen Tang +10 more
doaj +1 more source
Mechanism of Abnormal Coagulation Induced by Tigecycline in Cancer Patients
Frontiers in Pharmacology, 2022 Tigecycline is a broad-spectrum active intravenous antibiotic that is active against methicillin-resistant staphylococcus aureus. In Phase 3 and 4 clinical trials, increased all-cause mortality was observed in patients treated with tigecycline compared ...
Li-Hua Sun +9 more
doaj +1 more source
, 2022 The increasing incidence of tigecycline resistance undoubtedly constitutes a serious threat to global public health. The combination therapies had become the indispensable strategy against this threat. Herein, 11 clinical tigecycline-resistant Klebsiella
Lang Sun (1688164) +7 more
core +1 more source
Tigecycline: its potential for treatment of brucellosis
, 2007 The in vitro efficacy and synergistic activity of tigecycline in comparison with other antimicrobials used in brucellosis, were tested for 16 Brucella melitensis strains by the E-test method.
MURAT DİZBAY
core +2 more sources
Journal of Translational Medicine, 2023 Background Despite recent advances in locoregional, systemic, and novel checkpoint inhibitor treatment, hepatocellular carcinoma (HCC) is still associated with poor prognosis.
Dominik T. Koch +14 more
doaj +1 more source
British Journal of Clinical Pharmacology, EarlyView.Abstract Antimicrobial stewardship (AMS) programs were introduced to promote the judicious use of antimicrobials and to combat antimicrobial resistance. Quantifying antibiotic consumption is an important part of AMS initiatives to achieve these objectives.
Marjan Kandimahforoujaki +3 more
wiley +1 more source